Dempze Nancy E lifted its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 25,301 shares of the company’s stock after purchasing an additional 218 shares during the quarter. Procter & Gamble comprises about 2.3% of Dempze Nancy E’s investment portfolio, making the stock its 17th largest position. Dempze Nancy E’s holdings in Procter & Gamble were worth $4,031,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Kingstone Capital Partners Texas LLC boosted its position in shares of Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after buying an additional 76,017,350 shares in the last quarter. Northern Trust Corp boosted its position in shares of Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock worth $5,051,930,000 after buying an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock worth $3,660,737,000 after buying an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. boosted its position in shares of Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock worth $2,966,252,000 after buying an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in shares of Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock worth $2,947,146,000 after buying an additional 1,018,865 shares in the last quarter. 65.77% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
A number of research analysts have issued reports on the stock. BNP Paribas Exane reduced their target price on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. BNP Paribas restated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a report on Friday, August 15th. Bank of America reduced their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a “buy” rating on the stock in a report on Wednesday. Weiss Ratings restated a “hold (c+)” rating on shares of Procter & Gamble in a report on Wednesday. Finally, Barclays reduced their target price on shares of Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating on the stock in a report on Wednesday, October 1st. Eleven equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $172.58.
Insider Activity at Procter & Gamble
In related news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction that occurred on Thursday, August 21st. The shares were sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the completion of the sale, the chief executive officer owned 34,978 shares of the company’s stock, valued at approximately $5,532,120.48. This represents a 22.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jon R. Moeller sold 40,119 shares of the stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $6,309,515.13. Following the sale, the chief executive officer directly owned 319,375 shares of the company’s stock, valued at approximately $50,228,106.25. This trade represents a 11.16% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 149,763 shares of company stock worth $23,421,279. Corporate insiders own 0.20% of the company’s stock.
Procter & Gamble Trading Down 1.2%
NYSE PG opened at $150.67 on Thursday. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The company has a 50-day moving average of $155.26 and a 200-day moving average of $159.72. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The company has a market cap of $352.64 billion, a P/E ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, beating analysts’ consensus estimates of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The company had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. During the same quarter in the prior year, the company posted $1.40 EPS. The company’s quarterly revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current year.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
- Five stocks we like better than Procter & Gamble
- 3 Warren Buffett Stocks to Buy Now
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- What Are Treasury Bonds?
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- How to Use the MarketBeat Excel Dividend Calculator
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.